Anondita Medicare Ltd
Founded in March 2024, Anondita Medicare Limited manufactures flavored male condoms, with its flagship product branded as “COBRA.”[1]
- Market Cap ₹ 2,143 Cr.
- Current Price ₹ 1,185
- High / Low ₹ 1,316 / 262
- Stock P/E 79.9
- Book Value ₹ 62.5
- Dividend Yield 0.00 %
- ROCE 39.6 %
- ROE 37.9 %
- Face Value ₹ 10.0
Pros
- Company has a good return on equity (ROE) track record: 3 Years ROE 44.3%
Cons
- Stock is trading at 19.0 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Fast Moving Consumer Goods Fast Moving Consumer Goods Personal Products Personal Care
Part of Nifty SME Emerge
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2024 1m | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| 0 | 61 | 112 | |
| 0 | 43 | 72 | |
| Operating Profit | 0 | 18 | 39 |
| OPM % | 30% | 35% | |
| 0 | 0 | 2 | |
| Interest | 0 | 3 | 3 |
| Depreciation | 0 | 1 | 1 |
| Profit before tax | 0 | 14 | 37 |
| Tax % | 25% | 27% | |
| 0 | 11 | 27 | |
| EPS in Rs | 0.00 | 8.12 | 14.83 |
| Dividend Payout % | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 85% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 148% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 44% |
| Last Year: | 38% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Equity Capital | 0.10 | 13 | 18 |
| Reserves | 0 | 15 | 95 |
| 0 | 27 | 33 | |
| 0 | 9 | 17 | |
| Total Liabilities | 0 | 64 | 163 |
| 0 | 13 | 81 | |
| CWIP | 0 | 6 | 0 |
| Investments | 0 | 4 | 4 |
| 0 | 41 | 79 | |
| Total Assets | 0 | 64 | 163 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| -0 | 6 | 4 | |
| 0 | -23 | -61 | |
| 0 | 17 | 67 | |
| Net Cash Flow | 0 | 0 | 9 |
| Free Cash Flow | -0 | -14 | -59 |
| CFO/OP | 36% | 18% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Debtor Days | 100 | 124 | |
| Inventory Days | 115 | 101 | |
| Days Payable | 45 | 59 | |
| Cash Conversion Cycle | 170 | 166 | |
| Working Capital Days | 101 | 140 | |
| ROCE % | 62% | 40% |
Insights
In beta| Jan 2026 | Mar 2027 (P) | |
|---|---|---|
| Installed Manufacturing Capacity million pieces per annum |
|
|
| Capacity Under Trial Production million pieces per annum |
||
| Existing Capacity Utilization million pieces per annum |
||
| Existing Capacity Utilization (%) % |
||
| IPO Proceeds Re-allocation to Working Capital INR Lakhs |
||
| IPO Proceeds Utilized (Total) INR Lakhs |
||
| IPO Unutilized Amount INR Lakhs |
||
| L1 GeM Tender Supply Volume (Condoms) pieces |
||
| L1 GeM Tender Supply Volume (Family Planning Items) pieces |
||
| Order Value (CMSS GeM Tender) INR |
||
| Projected Turnover for FY2025-26 INR Crores |
||
| Target Capacity Expansion (Noida Facility) million pieces per annum |
||
Extracted by Screener AI
Documents
Announcements
-
Analysts/Institutional Investor Meet/Con. Call Updates
2 June 2026 - Released transcript of May 27 H2/FY26 earnings call; FY26 revenue Rs137.42 crore, PAT Rs34.30 crore.
-
Amendment to AOA/MOA
1 June 2026 - EGM on May 28, 2026 approved MoA amendment to expand product objects.
-
Shareholders meeting
1 June 2026 - EGM voting results: warrants to promoters, RPTs, MOA amendment, and managerial pay hikes approved on 28 May 2026.
-
Press Release
30 May 2026 - Anondita Medicare secures first export order worth ₹43.14 crore under South African government condom tender, execution by Sep 30, 2026.
-
Bagging/Receiving of orders/contracts
30 May 2026 - Anondita Medicare received first South African tender export order worth about Rs. 43.14 crore for 50 containers.
Annual reports
No data available.
Business Profile:[1]
Anondita Medicare manufactures male (and recently, female) condoms, flagship brand “COBRA,” with in-house printing/packaging and 100% electronic testing.